semaglutide weight loss ri Commentary: New obesity drugs face coverage cuts despite life-saving potential Semaglutide Weight Loss Injections &

GLP-1 (Glucagon-Like Peptide-1) medications have become a breakthrough solution for improving weight loss outcomes and controlling blood sugar levels

While both medications are effective for weight loss and blood sugar control, tirzepatides dual-action approach may lead to more pronounced effects

PMC 7674743

doi: 10.3389/fphar.2014.00170 Received 01 May 2014 Accepted 30 June 2014 Published 16 July 2014 Volume 5 - 2014 Edited by Alfonso Pompella, Universit di Pisa, Italy Reviewed by George Anthony Oyler, Synaptic Research, USA

Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions [press release]